Sweden is a key player in the European pharmaceutical market. With rising healthcare expenditures, the market outlook remains promising. National regulations require that any medicinal product be approved by the Medical Products Agency of Sweden prior to being marketed for human use. In accordance with Directive 2001/83/EC, all new medicinal products must be registered through a Marketing Authorization Application (MAA) following designated procedures
WhatsApp us